Press Release

September 12, 2024 07:30 AM Eastern Daylight Time
ASHBURN, Va.--(BUSINESS WIRE) – I2Pure is excited to announce a patent pending milestone achievement in iodine technology. Known for its expertise in iodine science and innovation, I2Pure has developed a novel and proprietary methodology to infuse nano particles with iodine that results in shelf-stable, pH-neutral iodine solutions. Using this technology, the efficacy of existing iodine products can be improved, and new iodine products can be developed that were previously out-of-reach to science and medicine. I2Pure’s breakthrough process is environmentally friendly, non-toxic, and cost-effective, consuming a fraction of the energy previously required to combine iodine with nano materials.

Toronto, Ontario--(Newsfile Corp. - July 31, 2024) – Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company"), through its water filtration subsidiary, Toppen Health, Inc. ("Toppen"), is excited to announce that it has entered into a license agreement (the "License Agreement") with I2Pure Corp. ("I2Pure") for the worldwide rights to its patented molecular iodine for use in water disinfection applications, enhancing Toppen's advanced water filtration systems.

I2Pure is a healthcare technology company focused on leveraging the natural antimicrobial power of molecular iodine to fight pathogens and reduce infection risks. "I've been intrigued by the potential use of iodine's natural antimicrobial capabilities in water disinfection for many years," says Owen Boyd, CEO of Toppen. "This license agreement has made that potential a reality. We can now talk about previously unattainable filtration goals. Our unique filter design will remove pathogens from any water source while continually releasing I2Pure's molecular iodine to protect water lines from biofilm and pathogens, greatly enhancing our ability to filter and disinfect water from any source."

Toppen filters have an outer filtration layer that pre-treats the water, removing contaminants. Its patented Center Core technology then allows for a slow-release of disinfectant material, in this case molecular iodine, ensuring the right amount of disinfectant is effectively and safely added to the water. The result of this process is water that is virtually 100% clean of any bacteria, pathogens, per- and polyfluoroalkyl substance ("PFAS" or "forever chemicals"), and pharmaceuticals.

"Millions of dollars are spent every year in the dental and healthcare industries, testing and shocking water lines, which still has an unsatisfactory rate of success," Mr. Boyd adds. "I2Pure has been a tremendous partner in helping us to realize our vision for improved water safety. Their scientific team exceeded our expectations for delivery of slow-release iodine that incorporates seamlessly into our Center Core filtration devices. Toppen's advanced water filtration solutions, combined with I2Pure's molecular iodine, can facilitate ion exchange, sorbent, and membrane filtration, along with many other types of media for separation, ultimately ensuring we can remove or neutralize any and all contaminants in any water supply effectively and affordably, without any guesswork."  more ...

               Ask a question

Press Release

Ashburn, Virginia – April 16, 2024 – Today, I2Pure and Toppen Health are excited to announce a new partnership aimed at forever changing water disinfection. On the foundation of their respective patent-protected and patent-pending technologies, the combination of I2Pure’s and Toppen Health’s approaches to water disinfection will create unmatched capability to filter and deliver clean water for endless applications.

Toppen Health is dedicated to water filtration. Their founder and CEO, Owen Boyd, is a long-time industry leader in water filtration, having invented and commercialized several novel systems currently used for water filtration in more than 75% of dental facilities in North America and Canada. Now at the helm of Toppen Health, Boyd remains committed to improving the availability of clean water around the world.

I2Pure is a healthcare technology company focused on leveraging the natural antimicrobial power of molecular iodine to fight pathogens and reduce infection risks in healthcare and a variety of other market segments. I2Pure’s iodine technologies can neutralize all known pathogens, whether bacterial, viral, or fungal.

“I2Pure could not be more excited at this new partnership with Toppen Health. With Toppen, we have a partner that shares a common goal of reliably disinfecting water at a volume and cost that is unmatched globally,” said Jeff Jochims, I2Pure CEO. more ...

               Ask a question

Press Release

Ashburn, Virginia – November 7, 2023 – Today, I2Pure announced the hiring of its new Chief Executive Officer, Jeffrey Jochims, effective November 1, 2023. Jeff succeeds I2Pure Founder Douglas Spitz, who is transitioning to the role of Executive Chair. Jochims also joins the I2Pure Board of Directors.

Jochims assumes this role following more than 25 years of leadership in the life sciences and healthcare industries, including long executive tenures at industry leaders Thermo Fisher Scientific and Owens & Minor. In addition, Jochims has deep experience in entrepreneurial start-ups as well as global life sciences and healthcare companies of all sizes. Businesses under Jochims’ influence have consistently delivered customer-centric operational excellence and market share gains.

“I2Pure has made tremendous progress since our formation only a few years ago. We’re elated to have someone of Jeff’s experience and capabilities join our company as Chief Executive Officer,” said Doug Spitz, I2Pure Founder. “Based on the incredible reception to our innovative iodine applications and the momentum that we’re building, more ...

               Ask a question

I2Pure awarded 2nd place in the International Competition Genius Challenge

In order to promote the technological development of solutions around the use and applications of iodine and its derivatives, and in line with its commitment to enabling a more sustainable industry and making the world a better place to live, SQM, the leader and main producer of iodine globally with support of Expande, launched “Genius”; an open innovation call that seeks identifying the best solutions that encourage the use of this element and its derivatives in Chile and at an international level.

Molecular iodine is not responsible for cytotoxicity in iodophors

Journal of Hospital Infection - February 4, 2022

I2PURE recognized as the Runner Up winner in the Tech Venture category.

Loudoun Economic Development - July 28, 2021